Published : 24 Dec 2025
A. Why Market Access teams require timely and credible insights: Market Access teams work in rapidly evolving environments where payer demands, clinical changes and competition change rapidly. To build compelling value stories, teams must act as soon as information reaches them.
For this reason, the need for sophisticated healthcare analytics software has risen sharply. Timely insights support pricing, reimbursement dialogues and alignment of evidence with payer needs.
B. The role of real-time data to inform payer strategies: Payer strategies depend on accurate and current evidence. Real-time intelligence gives teams an understanding of current treatment patterns, economic factors, and policy changes that set the stage.
Having a mechanism that tracks signals in real time empowers Market Access teams to act proactively rather than be reactive too late. Real-time context also enhances collaborative alignment to HEOR functions and ensures evidence remains current to payers.
C. Summary of Pienomial’s Knolens Edge as a real-time insights platform: KnoLens Edge is designed to provide continuous intelligence to Market Access and HEOR teams. As advanced healthcare analytics software, it captures conversations, trends, and evolving evidence from payer interactions, symposiums and expert dialogue.
Knolens Edge serves as a force multiplier and accelerates the timeframe on what could take an individual team an obscene amount of time to develop.
A. Data lag, dated information: Traditional analysis often relies on quarterly reports, static examination from literature reviews, and manually collected observations. This introduces a large data lag. When the information is received weeks or months after an event, Market Access teams cannot make timely decisions. This process is slow and prevents teams from anticipating payer issues and competitor actions.
B. Restricted visibility into KOL discussions: KOLs control clinical perceptions and drive payer rationalisation. Without real-time access to KOLs' opinions, teams lose meaningful signals that could change therapy positioning. Static tools do not provide the thoroughness to capture KOL's evolving sentiment. This absence highlights the utility of a HEOR insights platform, where evidence can be tracked interactively.
C. Slow decision timelines in HEOR and pricing: The production of insights takes time, delaying pricing submissions, updating economic models, and planning reimbursement. The Market Access team must be fast to align with HEOR colleagues to maintain powerful evidence stories. Without continuous intelligence, timelines can shift and opportunities become lost.
A. Contextual analytics powered by AI to accelerate intelligence: AI enhances the power of intelligence by creating real-time intelligence. When teams have advanced technologies that provide real-time analytics using healthcare data, teams work more efficiently to synthesise and disrupt a raft of scientific literature. AI takes unstructured data and organises it into structured themes that highlight safety signals, unmet needs, comparable effectiveness insights, and more. This removes manual analytic work and provides a faster pathway to strategic readiness for teams.
B. Predicting market and payer dynamics: Predictive analytics is more than early warning signs of changes in the market. Long before the formal report is published, AI can find clues that will signal industry developments and payer assessments. Signals from the clinical, policy and payer arena can be connected to give teams time to proactively prepare for their evidence base to meet payer decision criteria, competitive anticipation, and execution.
C. Insights into actionable strategy: Insights gathered in real time can have an impact on an organisation's value once translated into specific recommendations. AI-powered synthesised interpretation identifies implications for value messages, gaps in evidence for leveraging and pricing considerations. This creates cross-functional communications and greater confidence to act strategically on reliable intelligence from a HEOR Insights platform.
A. Capturing live evidence from conferences and advisory boards: Knolens Edge continuously collects insights from scientific meetings, payer workshops, medical congresses and advisory boards. As a modern healthcare analytics software, it transforms dispersed conversations into a unified intelligence stream. Teams gain immediate visibility into evolving evidence without waiting for post-event summaries or static reports.
B. Transforming raw insights into strategic recommendations: Knolens Edge interprets information with contextual understanding, helping Market Access teams identify relevance for their therapeutic area. It highlights competitive signals, clinical turning points and reimbursement considerations. These transformations give teams an opportunity to refine strategy far earlier than traditional review cycles allow.
C. Real-world example improving speed to market decisions: A Market Access team preparing for a therapy launch can use Knolens Edge to track clinical endorsements, real-time payer sentiment, and risk-benefit discussions. This helps refine pricing models and reimbursement messages instantly. The platform also supports how to use real-time KOL insights for market access decisions, giving teams a practical path to making informed choices that improve time to market.
A. Improved collaboration and alignment: Knolens Edge creates a unified source of truth for HEOR Market Access medical affairs and pricing functions. Shared insights lead to aligned communication strategies and informed evidence planning. Collaborative intelligence ensures that all stakeholders work from the same understanding of real-world developments.
B. Data-backed payer engagement and communication: With insights sourced from real-time data analytics in healthcare, teams communicate more confidently with payers. Evidence is always current, allowing pricing and reimbursement discussions to be built on the latest real-world context. Using structured intelligence framed by healthcare analytics software gives teams a strong advantage in negotiations.
A. Rise of continuous insight systems: The future of Market Access depends on ongoing intelligence instead of episodic updates. Continuous systems offer streams of evidence that support proactive planning, informed forecasting and rapid alignment. As medical information expands, continuous platforms will become the expected standard for evidence-based decision making.
B. How Pienomial Edge sets the standard for real-time healthcare analytics: Pienomial Knolens Edge brings together clinical context, payer insights and scientific intelligence with unmatched speed and accuracy. As an advanced healthcare analytics software, it leads the transition from static evidence systems to continuous learning environments. It also operates as a global engine of real-time insights that support stronger HEOR and Market Access performance.
A. Recap of the value of real-time insights: Real-time evidence empowers teams to act faster, make informed decisions and stay ahead in dynamic healthcare landscapes. Continuous monitoring, predictive analytics and AI-driven interpretation strengthen every aspect of Market Access planning.
With support from an integrated HEOR insights platform, teams gain a strategic edge grounded in accuracy and relevance.
B. Encourage adoption of Knolens Edge for agile, informed Market Access: Knolens Edge provides the intelligence infrastructure needed for modern Market Access success. With its real-time capabilities, actionable interpretation, and seamless collaboration features, it positions teams to lead with confidence.
Organisations aiming to accelerate decisions and improve outcomes can depend on Knolens Edge as their core intelligence engine.
